NEW YORK (GenomeWeb News) – Investigators at the Fred Hutchinson Cancer Research Center will use a $4 million award from the National Cancer Institute to identify new classes of drug targets and develop criteria for stratifying patients based on who will benefit from those new therapeutics, the center said on Tuesday.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.